SurgiVance, Inc. is developing a direct-to-digital pathology platform that combines a point-of-care tabletop imager, AI-powered image processing, and disposable tissue specimen cassettes for oncology care and research. Founded by Daniel S. Gareau, Ph.D., the company supports workflows ranging from clinical research to surgical margin screening and primary diagnosis, while noting that its technology has not yet been reviewed by the FDA for patient care. Its web-based application lets users upload paired confocal images, apply digital staining, and review the results online.
SurgiVance, Inc. registered corporation in the state of Delaware
Registration
SurgiVance trademark
Registration
OneVueOneVue develops ONVIEW, a wearable eye-imaging headset that combines precision optics with AI-assisted analysis to help clinicians perform specialist-level eye examinations beyond the traditional clinic. Founded by a team of ophthalmologists, engineers, and designers, the company is building portable imaging technology for underserved communities as well as existing healthcare practices. Its products are currently under development and are not cleared for sale in the United States.
IdentifySensors BiologicsCleveland-based IdentifySensors Biologics is developing Check4, a portable digital diagnostic platform that uses graphene-based printed biosensors to detect infectious pathogens and cancer biomarkers from saliva or blood. Founded by trauma surgeon and former NASA medical consultant Greg Hummer and data scientist Matthew Hummer, the company connects its electronic tests to cloud-based analysis rather than relying on conventional laboratory workflows. Its products remain under development and are not yet approved for sale.SHAKER HEIGHTS, OH
Pharos Imaging, IncPharos Imaging is developing a compact optical coherence tomography platform designed to bring microscopic imaging out of specialist back rooms and into portable, everyday settings. Founded around a team led by co-founders Dr. David Rubaltelli and Dr. Xingchen Ji, the company is building a battery-powered, cloud-connected system that is smaller than a cell phone and intended to broaden access to OCT for home monitoring and screening.NEW YORK, NY
Lumenate MedicalLumenate Medical is developing a catheter-based cystoscope that lets non-urologist providers collect bladder images for remote review by board-certified urologists. Founded by a team that includes Johns Hopkins engineering and medical expertise, the Baltimore-based company is focused on shortening long waits for bladder cancer screening while keeping specialists in the decision-making loop. Its device remains in development and is not yet cleared or approved for sale by the U.S. Food and Drug Administration.